Destia lands new backers, eyes Europe after scaling to €250M revenue
What's the deal? DestiaDealroom has a profile for this one. Try Dealroom →, France's leading home care provider for seniors and people with disabilities, has secured a fresh round of growth equity to fund its next expansion phase across France and Europe.
New investors Bpifrance, Three HillsDealroom has a profile for this one. Try Dealroom →, Turenne SantéDealroom has a profile for this one. Try Dealroom →, and VYVDealroom has a profile for this one. Try Dealroom → join the group. Historical shareholders — including majority backer Siparex ETIDealroom has a profile for this one. Try Dealroom →, BNP Paribas DéveloppementDealroom has a profile for this one. Try Dealroom →, MACSFDealroom has a profile for this one. Try Dealroom →, AzulisDealroom has a profile for this one. Try Dealroom →, and Après demainDealroom has a profile for this one. Try Dealroom → — are reinvesting, with Eurazeo providing financing.
Why now? Since Siparex ETI took a majority stake in 2021, Destia's turnover has surged from €100 million to over €250 million in 2025.
That growth came from more than 40 acquisitions, which took the company into Spain, Ireland, Germany, and Switzerland. Founded in 2006 by Xavier Mura, Destia now runs 180 agencies across France and Europe.
"This change in our shareholding structure marks a new stage of growth for Destia," said Mura, the company's founding president. He added that the deal unites new and historical partners around a "common ambition: to build the future of home care by placing employees at the heart of the company's project."
What could go wrong? Rapid acquisition-led growth carries integration risk, especially across four new markets with different regulations and labour rules.
Home care also runs on thin margins and depends heavily on staffing — a persistent challenge in a sector facing chronic worker shortages.
The signal: Europe's ageing population is driving investor appetite for home care, a defensive sector with steady demand.
Destia's jump from €100 million to €250 million in four years shows how private capital is consolidating a fragmented market. Expect more roll-ups as investors chase scale in senior care across the continent.
Read more: Investors in Healthcare
Image credit: agilemktg1
